Friday, March 30, 2012

Roche to file T-DM1 breast cancer drug on good data

ZURICH (Reuters) - Roche said patients with an aggressive type of breast cancer lived longer after taking its experimental "armed antibody" drug without the disease worsening than those on a mix of GlaxoSmithKline drug Tykerb and Roche's Xeloda.

lynn smith collision insurance for auto repair shops chapmans auto body

No comments:

Post a Comment